Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 May;66(2):135-44.
doi: 10.1016/j.critrevonc.2007.10.001. Epub 2007 Nov 19.

Immunotherapies for Hodgkin's lymphoma

Affiliations
Review

Immunotherapies for Hodgkin's lymphoma

Yvette L Kasamon et al. Crit Rev Oncol Hematol. 2008 May.

Abstract

Multiple immune evasion strategies characterize the pathobiology of Hodgkin's lymphoma. These must be considered when developing and testing immunotherapeutic approaches for this disease. The clinical experience with adoptive immunotherapy of Epstein-Barr virus positive tumors, and with monoclonal antibodies directed against CD30, CD20, and other antigens, is herein reviewed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Poppema S, van den Berg A. Interaction between host T cells and Reed–Sternberg cells in Hodgkin lymphomas. Semin Cancer Biol. 2000;10:345–50. - PubMed
    1. Marshall NA, Christie LE, Munro LR, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood. 2004;103:1755–62. - PubMed
    1. Beck A, Pazolt D, Grabenbauer GG, et al. Expression of cytokine and chemokine genes in Epstein–Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol. 2001;194:145–51. - PubMed
    1. Poppema S, Potters M, Visser L, van den Berg AM. Immune escape mechanisms in Hodgkin's disease. Ann Oncol. 1998;9(Suppl 5):S21–4. - PubMed
    1. van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed–Sternberg cells. A possible explanation for the characteristic T cell infiltrate in Hodgkin's lymphoma. Am J Pathol. 1999;154:1685–91. - PMC - PubMed

MeSH terms